Last reviewed · How we verify

GAMALINE® + HIPERICIN®

Phytopharm Consulting Brazil · Phase 3 active Small molecule

GAMALINE® + HIPERICIN® is a phytopharmaceutical combination that enhances immune function and reduces inflammatory markers through polyphenolic and flavonoid constituents.

GAMALINE® + HIPERICIN® is a phytopharmaceutical combination that enhances immune function and reduces inflammatory markers through polyphenolic and flavonoid constituents. Used for Immune system support and inflammatory conditions (Phase 3 indication not fully specified in public domain).

At a glance

Generic nameGAMALINE® + HIPERICIN®
Also known asGAMALINE® BATCH 8663A0 MS 1.1860.0061.002-9, HIPERICIN® BATCH 867911 MS 1.1860.0003.003-0
SponsorPhytopharm Consulting Brazil
Drug classPhytopharmaceutical combination / Immunomodulator
ModalitySmall molecule
Therapeutic areaImmunology / Inflammation
PhasePhase 3

Mechanism of action

GAMALINE® (gamma-linolenic acid derivative) and HIPERICIN® (hypericum perforatum extract) work synergistically to modulate immune response and reduce systemic inflammation. The combination targets multiple inflammatory pathways and may enhance natural killer cell activity and cytokine regulation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results